B. Riley Financial restated their buy rating on shares of Oncology Institute (NASDAQ:STLN – Free Report) in a research note released on Friday,Benzinga reports. They currently have a $10.00 price target on the stock, down from their prior price target of $11.00. Other equities analysts have also issued reports about the stock. Weiss Ratings reiterated […]

Hut 8 (NASDAQ:HUT – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at B. Riley Financial in a research note issued to investors on Friday, Benzinga reports. They currently have a $132.00 target price on the stock, down from their prior target price of $134.00. B. Riley Financial‘s price objective suggests […]

Gladstone Commercial (NASDAQ:GOOD – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at B. Riley Financial in a research report issued on Wednesday, Benzinga reports. They currently have a $11.50 price target on the real estate investment trust’s stock, down from their prior price target of $12.50. B. Riley Financial‘s price objective […]

PayPal (NASDAQ:PYPL – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at BTIG Research in a note issued to investors on Tuesday, Benzinga reports. PYPL has been the subject of a number of other reports. Robert W. Baird increased their target price on shares of PayPal from $50.00 to $57.00 and […]